In:
Otology & Neurotology, Ovid Technologies (Wolters Kluwer Health), Vol. 43, No. 10 ( 2022-12), p. e1174-e1179
Abstract:
To determine the usefulness of a personalized tool and its effect on the decision-making process for those with vestibular schwannoma (VS). Study Design Prospective study. Setting Single institution, academic tertiary care lateral skull base surgery program. Patients Patients diagnosed with VS. Interventions A comprehensive clinical decision support (CDS) tool was constructed from a previously published retrospective patient-reported data obtained from members of the Acoustic Neuroma Association from January to March 2017. Demographic, tumor, and treatment modality data, including associated side effects, were collected for 775 patients and integrated in an interactive and personalized web-based tool. Main Outcome Measures Pre- and posttool questionnaires assessing the process of deciding treatment for VS using a decisional conflict scale (DCS) and satisfaction with decision (SWD) scale were compared. Results A pilot study of 33 patients evaluated at a single institution tertiary care center with mean ± SD age of 63.9 ± 13.5 years and with average tumor size of 7.11 ± 4.75 mm were surveyed. CDS implementation resulted in a mean ± SD total DCS score decrease from 43.6 ± 15.5 to 37.6 ± 16.4 ( p 〈 0.01) and total SWD score increase from 82.8 ± 16.1 to 86.2 ± 14.4 ( p = 0.04), indicating a significant decrease in decisional conflict and increase in satisfaction. Conclusions Implementing a decision-making tool after diagnosis of VS reduced decisional conflict and improved satisfaction with decision. Patients considered the tool to be an aid to their medical knowledge, further improving their comfort and understanding of their treatment options. These findings provide a basis for developing predictive tools that will assist patients in making informed medical decisions in the future.
Type of Medium:
Online Resource
ISSN:
1537-4505
,
1531-7129
DOI:
10.1097/MAO.0000000000003719
Language:
English
Publisher:
Ovid Technologies (Wolters Kluwer Health)
Publication Date:
2022
detail.hit.zdb_id:
2058738-7
Bookmarklink